Oral Iron for IBD Patients: Lessons Learned at Time of COVID-19 Pandemic.
Identifieur interne : 000A08 ( Main/Exploration ); précédent : 000A07; suivant : 000A09Oral Iron for IBD Patients: Lessons Learned at Time of COVID-19 Pandemic.
Auteurs : Ferdinando D'Amico [Italie, France] ; Laurent Peyrin-Biroulet [France] ; Silvio Danese [Italie]Source :
- Journal of clinical medicine [ 2077-0383 ] ; 2020.
Abstract
Anemia is a frequent manifestation in patients with chronic inflammatory bowel disease (IBD) and requires tight monitoring and adequate supplementary therapy. Intravenous iron is the first-line treatment in subjects with moderate-severe anemia, active disease, or oral iron intolerance. On the other hand, oral iron is recommended in patients with mild anemia and inactive disease. However, during the current coronavirus pandemic, hospital activities have significantly changed, and all non-essential procedures, including non-urgent iron infusions, have been rescheduled. Oral iron, including both the traditional formulations with ferrous iron and the new ferric iron complexes, could constitute a valid alternative for anemia treatment. For this reason, we conducted a literature review, to summarize the scientific evidence on oral iron therapy in IBD patients with anemia.
DOI: 10.3390/jcm9051536
PubMed: 32438763
PubMed Central: PMC7290728
Affiliations:
- France, Italie
- Grand Est, Lombardie, Lorraine (région)
- Milan, Nancy, Vandœuvre-lès-Nancy
- Centre hospitalier régional et universitaire de Nancy, Université de Lorraine
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Oral Iron for IBD Patients: Lessons Learned at Time of COVID-19 Pandemic.</title><author><name sortKey="D Amico, Ferdinando" sort="D Amico, Ferdinando" uniqKey="D Amico F" first="Ferdinando" last="D'Amico">Ferdinando D'Amico</name><affiliation wicri:level="3"><nlm:affiliation>Department of Biomedical Sciences, Humanitas University, 20090 Pieve Emanuele, Milan, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Biomedical Sciences, Humanitas University, 20090 Pieve Emanuele, Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Department of Gastroenterology and Inserm NGERE U1256, University Hospital of Nancy, University of Lorraine, 54500 Vandoeuvre-lès-Nancy, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Gastroenterology and Inserm NGERE U1256, University Hospital of Nancy, University of Lorraine, 54500 Vandoeuvre-lès-Nancy</wicri:regionArea><placeName><region type="region" nuts="2">Grand Est</region><region type="old region" nuts="2">Lorraine (région)</region><settlement type="city">Vandœuvre-lès-Nancy</settlement></placeName></affiliation></author><author><name sortKey="Peyrin Biroulet, Laurent" sort="Peyrin Biroulet, Laurent" uniqKey="Peyrin Biroulet L" first="Laurent" last="Peyrin-Biroulet">Laurent Peyrin-Biroulet</name><affiliation wicri:level="3"><nlm:affiliation>Department of Gastroenterology and Inserm NGERE U1256, University Hospital of Nancy, University of Lorraine, 54500 Vandoeuvre-lès-Nancy, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Gastroenterology and Inserm NGERE U1256, University Hospital of Nancy, University of Lorraine, 54500 Vandoeuvre-lès-Nancy</wicri:regionArea><placeName><region type="region" nuts="2">Grand Est</region><region type="old region" nuts="2">Lorraine (région)</region><settlement type="city">Vandœuvre-lès-Nancy</settlement></placeName><placeName><settlement type="city">Nancy</settlement><region type="old region" nuts="2">Lorraine (région)</region></placeName><orgName type="hospital" n="4">Centre hospitalier régional et universitaire de Nancy</orgName><orgName type="institution">Université de Lorraine</orgName></affiliation></author><author><name sortKey="Danese, Silvio" sort="Danese, Silvio" uniqKey="Danese S" first="Silvio" last="Danese">Silvio Danese</name><affiliation wicri:level="3"><nlm:affiliation>Department of Biomedical Sciences, Humanitas University, 20090 Pieve Emanuele, Milan, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Biomedical Sciences, Humanitas University, 20090 Pieve Emanuele, Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>IBD center, Department of Gastroenterology, Humanitas Clinical and Research Center, IRCCS, 20089 Rozzano, Milan, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>IBD center, Department of Gastroenterology, Humanitas Clinical and Research Center, IRCCS, 20089 Rozzano, Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32438763</idno><idno type="pmid">32438763</idno><idno type="doi">10.3390/jcm9051536</idno><idno type="pmc">PMC7290728</idno><idno type="wicri:Area/Main/Corpus">001167</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001167</idno><idno type="wicri:Area/Main/Curation">001167</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001167</idno><idno type="wicri:Area/Main/Exploration">001167</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Oral Iron for IBD Patients: Lessons Learned at Time of COVID-19 Pandemic.</title><author><name sortKey="D Amico, Ferdinando" sort="D Amico, Ferdinando" uniqKey="D Amico F" first="Ferdinando" last="D'Amico">Ferdinando D'Amico</name><affiliation wicri:level="3"><nlm:affiliation>Department of Biomedical Sciences, Humanitas University, 20090 Pieve Emanuele, Milan, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Biomedical Sciences, Humanitas University, 20090 Pieve Emanuele, Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Department of Gastroenterology and Inserm NGERE U1256, University Hospital of Nancy, University of Lorraine, 54500 Vandoeuvre-lès-Nancy, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Gastroenterology and Inserm NGERE U1256, University Hospital of Nancy, University of Lorraine, 54500 Vandoeuvre-lès-Nancy</wicri:regionArea><placeName><region type="region" nuts="2">Grand Est</region><region type="old region" nuts="2">Lorraine (région)</region><settlement type="city">Vandœuvre-lès-Nancy</settlement></placeName></affiliation></author><author><name sortKey="Peyrin Biroulet, Laurent" sort="Peyrin Biroulet, Laurent" uniqKey="Peyrin Biroulet L" first="Laurent" last="Peyrin-Biroulet">Laurent Peyrin-Biroulet</name><affiliation wicri:level="3"><nlm:affiliation>Department of Gastroenterology and Inserm NGERE U1256, University Hospital of Nancy, University of Lorraine, 54500 Vandoeuvre-lès-Nancy, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Gastroenterology and Inserm NGERE U1256, University Hospital of Nancy, University of Lorraine, 54500 Vandoeuvre-lès-Nancy</wicri:regionArea><placeName><region type="region" nuts="2">Grand Est</region><region type="old region" nuts="2">Lorraine (région)</region><settlement type="city">Vandœuvre-lès-Nancy</settlement></placeName><placeName><settlement type="city">Nancy</settlement><region type="old region" nuts="2">Lorraine (région)</region></placeName><orgName type="hospital" n="4">Centre hospitalier régional et universitaire de Nancy</orgName><orgName type="institution">Université de Lorraine</orgName></affiliation></author><author><name sortKey="Danese, Silvio" sort="Danese, Silvio" uniqKey="Danese S" first="Silvio" last="Danese">Silvio Danese</name><affiliation wicri:level="3"><nlm:affiliation>Department of Biomedical Sciences, Humanitas University, 20090 Pieve Emanuele, Milan, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Biomedical Sciences, Humanitas University, 20090 Pieve Emanuele, Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>IBD center, Department of Gastroenterology, Humanitas Clinical and Research Center, IRCCS, 20089 Rozzano, Milan, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>IBD center, Department of Gastroenterology, Humanitas Clinical and Research Center, IRCCS, 20089 Rozzano, Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation></author></analytic><series><title level="j">Journal of clinical medicine</title><idno type="ISSN">2077-0383</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Anemia is a frequent manifestation in patients with chronic inflammatory bowel disease (IBD) and requires tight monitoring and adequate supplementary therapy. Intravenous iron is the first-line treatment in subjects with moderate-severe anemia, active disease, or oral iron intolerance. On the other hand, oral iron is recommended in patients with mild anemia and inactive disease. However, during the current coronavirus pandemic, hospital activities have significantly changed, and all non-essential procedures, including non-urgent iron infusions, have been rescheduled. Oral iron, including both the traditional formulations with ferrous iron and the new ferric iron complexes, could constitute a valid alternative for anemia treatment. For this reason, we conducted a literature review, to summarize the scientific evidence on oral iron therapy in IBD patients with anemia.</div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32438763</PMID><DateRevised><Year>2020</Year><Month>06</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>May</Month><Day>19</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Oral Iron for IBD Patients: Lessons Learned at Time of COVID-19 Pandemic.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">E1536</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm9051536</ELocationID><Abstract><AbstractText>Anemia is a frequent manifestation in patients with chronic inflammatory bowel disease (IBD) and requires tight monitoring and adequate supplementary therapy. Intravenous iron is the first-line treatment in subjects with moderate-severe anemia, active disease, or oral iron intolerance. On the other hand, oral iron is recommended in patients with mild anemia and inactive disease. However, during the current coronavirus pandemic, hospital activities have significantly changed, and all non-essential procedures, including non-urgent iron infusions, have been rescheduled. Oral iron, including both the traditional formulations with ferrous iron and the new ferric iron complexes, could constitute a valid alternative for anemia treatment. For this reason, we conducted a literature review, to summarize the scientific evidence on oral iron therapy in IBD patients with anemia.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>D'Amico</LastName><ForeName>Ferdinando</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, 20090 Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Gastroenterology and Inserm NGERE U1256, University Hospital of Nancy, University of Lorraine, 54500 Vandoeuvre-lès-Nancy, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peyrin-Biroulet</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology and Inserm NGERE U1256, University Hospital of Nancy, University of Lorraine, 54500 Vandoeuvre-lès-Nancy, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Danese</LastName><ForeName>Silvio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, 20090 Pieve Emanuele, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IBD center, Department of Gastroenterology, Humanitas Clinical and Research Center, IRCCS, 20089 Rozzano, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">anemia</Keyword><Keyword MajorTopicYN="N">inflammatory bowel disease</Keyword><Keyword MajorTopicYN="N">iron deficiency</Keyword><Keyword MajorTopicYN="N">oral iron</Keyword></KeywordList><CoiStatement>F. D’Amico declares no conflict of interest. L. Peyrin-Biroulet personal fees from AbbVie, Janssen, Genentech, Ferring, Tillots, Pharmacosmos, Celltrion, Takeda, Boerhinger Ingelheim, Pfizer, Index Pharmaceuticals, Sandoz, Celgene, Biogen, Samsung Bioepis, Alma, Sterna, Nestle, Enterome, Allergan, MSD, Roche, Arena, Gilead, Hikma, Amgen, BMS, Vifor, Norgine; Mylan, Lilly, Fresenius Kabi, Oppilan Pharma, Sublimity Therapeutics, Applied Molecular Transport, OSE Immunotherapeutics, Enthera, Theravance ; grants from Abbvie, MSD, Takeda ; stock-options CTMA. S Danese has served as a speaker, consultant, and advisory board member for Schering-Plough, AbbVie, Actelion, Alphawasserman, AstraZeneca, Cellerix, Cosmo Pharmaceuticals, Ferring, Genentech, Grunenthal, Johnson and Johnson, Millenium Takeda, MSD, Nikkiso Europe GmbH, Novo Nordisk, Nycomed, Pfizer, Pharmacosmos, UCB Pharma, and Vifor.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>04</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>05</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>05</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32438763</ArticleId><ArticleId IdType="pii">jcm9051536</ArticleId><ArticleId IdType="doi">10.3390/jcm9051536</ArticleId><ArticleId IdType="pmc">PMC7290728</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Crohns Colitis. 2014 Aug;8(8):876-80</Citation><ArticleIdList><ArticleId IdType="pubmed">24486177</ArticleId></ArticleIdList></Reference><Reference><Citation>Intern Emerg Med. 2019 Apr;14(3):423-431</Citation><ArticleIdList><ArticleId IdType="pubmed">30499070</ArticleId></ArticleIdList></Reference><Reference><Citation>Scand J Gastroenterol. 2016 Jul;51(7):848-54</Citation><ArticleIdList><ArticleId IdType="pubmed">26880133</ArticleId></ArticleIdList></Reference><Reference><Citation>J Crohns Colitis. 2015 Mar;9(3):211-22</Citation><ArticleIdList><ArticleId IdType="pubmed">25518052</ArticleId></ArticleIdList></Reference><Reference><Citation>Inflamm Bowel Dis. 2015 Aug;21(8):1976-81</Citation><ArticleIdList><ArticleId IdType="pubmed">25844962</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutrients. 2018 Jan 13;10(1):</Citation><ArticleIdList><ArticleId IdType="pubmed">29342861</ArticleId></ArticleIdList></Reference><Reference><Citation>J Crohns Colitis. 2012 Apr;6(3):267-75</Citation><ArticleIdList><ArticleId IdType="pubmed">22405161</ArticleId></ArticleIdList></Reference><Reference><Citation>Gut. 2004 Aug;53(8):1190-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15247190</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Gastroenterol Hepatol. 2014 Dec;26(12):1385-91</Citation><ArticleIdList><ArticleId IdType="pubmed">25264983</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2017 Apr 29;389(10080):1741-1755</Citation><ArticleIdList><ArticleId IdType="pubmed">27914655</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2015 Feb 20;10(2):e0117383</Citation><ArticleIdList><ArticleId IdType="pubmed">25700159</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Gastroenterol Hepatol. 2020 May;17(5):253-255</Citation><ArticleIdList><ArticleId IdType="pubmed">32214232</ArticleId></ArticleIdList></Reference><Reference><Citation>J Crohns Colitis. 2016 Mar;10(3):239-54</Citation><ArticleIdList><ArticleId IdType="pubmed">26614685</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Apr 30;382(18):1708-1720</Citation><ArticleIdList><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2017 Apr 29;389(10080):1756-1770</Citation><ArticleIdList><ArticleId IdType="pubmed">27914657</ArticleId></ArticleIdList></Reference><Reference><Citation>Inflamm Bowel Dis. 2015 Mar;21(3):579-88</Citation><ArticleIdList><ArticleId IdType="pubmed">25545376</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2020 Apr 16;4:CD012005</Citation><ArticleIdList><ArticleId IdType="pubmed">32297974</ArticleId></ArticleIdList></Reference><Reference><Citation>J Crohns Colitis. 2014 Oct;8(10):1308-14</Citation><ArticleIdList><ArticleId IdType="pubmed">24721157</ArticleId></ArticleIdList></Reference><Reference><Citation>Aliment Pharmacol Ther. 2016 Aug;44(3):259-70</Citation><ArticleIdList><ArticleId IdType="pubmed">27237709</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Gastroenterol Hepatol. 2013 Dec;25(12):1456-63</Citation><ArticleIdList><ArticleId IdType="pubmed">24100539</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Opin Pharmacother. 2015;16(18):2859-67</Citation><ArticleIdList><ArticleId IdType="pubmed">26595432</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Gastroenterol. 2013 Dec;108(12):1877-88</Citation><ArticleIdList><ArticleId IdType="pubmed">24145678</ArticleId></ArticleIdList></Reference><Reference><Citation>Medicine (Baltimore). 2015 Jun;94(23):e963</Citation><ArticleIdList><ArticleId IdType="pubmed">26061331</ArticleId></ArticleIdList></Reference><Reference><Citation>Gut. 2020 Jun;69(6):981-983</Citation><ArticleIdList><ArticleId IdType="pubmed">32299837</ArticleId></ArticleIdList></Reference><Reference><Citation>Inflamm Bowel Dis. 2006 Feb;12(2):123-30</Citation><ArticleIdList><ArticleId IdType="pubmed">16432377</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Gastroenterol. 2009 Jun;104(6):1460-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19491860</ArticleId></ArticleIdList></Reference><Reference><Citation>Medicine (Baltimore). 2016 Jan;95(2):e2308</Citation><ArticleIdList><ArticleId IdType="pubmed">26765407</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>France</li><li>Italie</li></country><region><li>Grand Est</li><li>Lombardie</li><li>Lorraine (région)</li></region><settlement><li>Milan</li><li>Nancy</li><li>Vandœuvre-lès-Nancy</li></settlement><orgName><li>Centre hospitalier régional et universitaire de Nancy</li><li>Université de Lorraine</li></orgName></list><tree><country name="Italie"><region name="Lombardie"><name sortKey="D Amico, Ferdinando" sort="D Amico, Ferdinando" uniqKey="D Amico F" first="Ferdinando" last="D'Amico">Ferdinando D'Amico</name></region><name sortKey="Danese, Silvio" sort="Danese, Silvio" uniqKey="Danese S" first="Silvio" last="Danese">Silvio Danese</name><name sortKey="Danese, Silvio" sort="Danese, Silvio" uniqKey="Danese S" first="Silvio" last="Danese">Silvio Danese</name></country><country name="France"><region name="Grand Est"><name sortKey="D Amico, Ferdinando" sort="D Amico, Ferdinando" uniqKey="D Amico F" first="Ferdinando" last="D'Amico">Ferdinando D'Amico</name></region><name sortKey="Peyrin Biroulet, Laurent" sort="Peyrin Biroulet, Laurent" uniqKey="Peyrin Biroulet L" first="Laurent" last="Peyrin-Biroulet">Laurent Peyrin-Biroulet</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A08 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000A08 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32438763
|texte= Oral Iron for IBD Patients: Lessons Learned at Time of COVID-19 Pandemic.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32438763" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidFranceV1
| This area was generated with Dilib version V0.6.37. |  |